Several studies have shown a role for the involvement of interleukin (IL)-1 gene cluster polymorphisms in the risk of periodontal diseases. In the present study, we tested polymorphisms, derived from genes of the IL-1 cluster, for association with generalized aggressive periodontitis (GAP) through both allelic association and by constructing a linkage disequilibrium (LD) map of the 2q13-14 disease candidate region. The IL-1RN (VNTR) genotype distribution observed was significantly different in GAP and control subjects (P ¼ 0.019). We also observed some evidence for an association between GAP and the IL-1B þ 3953 polymorphism (P ¼ 0.039). The pattern of association in the region, represented as an LD map, identifies a recombination hot area between the IL-1B þ 3953 and IL-1B À511 polymorphisms. Multilocus modelling of association with disease gives a location for the peak association at the IL-1B þ 3953 marker, although support for the peak is not significant. Haplotype analysis identifies a IL-1B
Introduction
During the past two decades, linkage analysis has been extremely successful in localizing disease genes showing a Mendelian pattern of inheritance. Linkage disequilibrium (LD) analysis, which exploits recombination events over many generations for fine mapping, has also been used to test the involvement of candidate genes in diseases and to refine the location of disease genes in regions identified by linkage. [1] [2] [3] [4] Fairly recently, such association studies have been proposed as potentially powerful for detecting the many subtle genetic effects underlying susceptibility to common diseases. 5, 6 In contrast to linkage studies, which look for coinheritance of chromosomal regions with disease in families, association studies look for differences in the frequency of genetic variants between unrelated affected individuals and controls, with the expectation that a riskconferring variant and/or alleles on the disease haplotype will be more common in patients. 7, 8 However, within a candidate region, the patterns of association between markers and disease are known to be complex and unpredictable. For example, pairs of markers that are several kilobases apart might be in 'complete' LD, whereas nearby pairs of sites from the same region may be in weak LD. These fluctuations reflect past historical events, including the different ages of polymorphic variants or stochastic processes, including admixture, selection and genetic drift. Similarly, allelic heterogeneity, which may be present at each locus, complicates the analysis of complex diseases by reducing the power for association between a given polymorphism and an observable phenotype. 9, 10 Furthermore, there can be remarkable differences in the extent of association from one genomic region to another, 11 reflecting the location of recombination hot spots which generates a pattern of blocks of conserved LD and steps where LD breaks down. 12, 13 Ohashi et al 14 showed that one of the major difficulties in testing association in case-control association studies is attributable to the large number of SNPs that must be used. In fact, a marked reduction in the statistical power of LD studies arises from multiple testing and the extremely low P-values required after Bonferroni adjustment, which are unlikely to be achievable with realistic sample sizes.
Despite the problems posed by multiple testing and complex patterns of disease and marker association, LD mapping has considerable potential and there is great interest in using LD to resolve the genetics of complex diseases. Thus, it is essential to model patterns of association to exploit LD data effectively and to try to distinguish 'signal' from 'noise'.
Many methods have been formulated for using .multi-loci data, 10 among which a composite likelihood approach for the location of a major disease gene against a high-resolution marker map was described by Collins and Morton. 15 This method differs from other approaches by adopting the Malécot model to determine a maximum likelihood location for a putative disease locus in a candidate region. The model has several advantages: it accommodates multiple founder mutations, it easily allows the pooling of heterogeneous data from multiple studies and the application of this method to various data sets indicates a relatively high power. 15, 16 Moreover, the Malécot model provides a multiplepairwise test based on association (r), which, by estimating a small number of parameters, makes the heavy discount of the Bonferroni correction unnecessary.
This model was originally developed for major gene case and control haplotypes. 15 We describe here an extension of this method to a sample-based case-control study design, where marker gene frequencies in cases and controls permit reduction to a 2 Â 2 table, but the locus cannot be haplotyped. This method is illustrated through the analysis of five genetic polymorphisms at the interleukin (IL)-1 cluster genes and their possible association with generalized aggressive periodontitis (GAP) in unrelated Italian patients.
Aggressive periodontitis 17 represents an inflammatory disease with onset in the juvenile or early adult years and a rapidly progressive clinical course characterized by localized or generalized loss of alveolar bone. 18 Recently, some comprehensive and detailed reviews have presented convincing evidence for heritable components of both susceptibility and progression (or severity) of periodontal diseases. [19] [20] [21] [22] [23] Many studies have focused on the potential role of several cytokines involved in the inflammatory response, among which some of the most investigated are the IL-1a, IL-1b and IL-1Ra, [24] [25] [26] [27] [28] genes which are all located on the long arm of chromosome 2 (region 2q13-14).
In 1997, Kornman et al 29 found an association between polymorphisms in the IL-1A
À889 and IL-1B þ 3953 genes, and an increased severity of chronic periodontitis. This initial study has been the most influential in creating interest in gene polymorphisms and periodontal diseases.
The composite IL-1 genotype, known as periodontitisassociated genotype (PAG), obtained by the combination of the two rare alleles at the above mentioned SNPs, has been extensively investigated with respect to the form of periodontal disease (chronic vs aggressive), smoke, ethnic group, oral microbial pathogens present in the plaque biofilm and other periodontal clinical parameters related to inflammatory status or to the progression of the disease. 22, 23 Given the complex biology of IL-1 regulation and the extensive polymorphisms in the IL-1 gene cluster, it is likely that if IL-1 genes influence disease, then combinations of specific alleles will be important rather than individual alleles. Therefore, it is considered that knowledge of LD and population haplotypes in the IL-1 cluster will greatly aid rational design of experiments.
In the present study, we tested polymorphisms derived from the genes of the IL-1 cluster for association with GAP, in a case-control study using composite maximum likelihood and a statistical regression model, and by constructing an LD map of the chromosome 2q13-14 candidate region.
Results
The genotypic and allelic frequencies of the IL-1 markers in GAP patients and controls are presented in Figures 1  and 2 
IL-1B(+3953)
IL-1A(+4845) Figure 1 Genotypic frequencies of IL-1 cluster polymorphisms in GAP patients and healthy controls. The distribution of IL-1RN (VNTR) polymorphisms has been reduced to a diallelic system as described in the Results section.
LD analysis in a case-control study on GAP C Scapoli et al the Hardy-Weinberg test, 30 ensured that the controls marker typing showed no deviation from Hardy-Weinberg frequencies under the likelihood ratio Shannon test of w 2 (Table 1) . However, the TIC polymorphism showed a marked deviation from HWE and was omitted from further LD analysis. The microsatellite IL-1RN showed some deviation from Hardy-Weinberg equilibrium through the rare alleles 4 and 5. In order to perform the LD analysis, we reduced the 5 Â 2 table of the allele distribution observed in cases and controls to a 2 Â 2 table for disease allele Â marker allele, by subdividing the observed alleles in 'associated' and 'not associated' alleles following the procedure described in Collins and Morton. 15 We observed that allele 3 of the IL-1RN marker was the allele showing the lower P-value when association of alleles with the disease status was tested. Thus, we reduced the IL-1RN system to a diallelic system (the '3' allele vs the 'not 3' alleles) and the reduced IL-1RN system was in HW equilibrium (Table 1 , P ¼ 0.101).
To assess the evidence of association with GAP, each of the IL-1 markers was firstly analysed separately.
For IL-1B þ 3953 , a statistically significant difference was found between patients and controls in the allelic distribution (Table 2 ), but no significant difference was found for genotypic distribution (Figure 1 ). Allele 2 of the IL-1B marker was transmitted significantly more often than allele 1 to GAP-affected individuals (OR ¼ 1.90, 95% CI ¼ 1.02-3.51).
For the IL-1RN (VNTR), a statistically significant difference was found between patients and controls in the genotypic distribution ( Figure 1 , MLw 2 [2] ¼ 7.97, P ¼ 0.019), but no significant difference was found for allelic distribution (Table 2) . For the other IL-1 cluster polymorphisms, no significant differences were found between patients and controls for both genotypic and allelic frequencies ( Figure 1 and Table 2 , respectively).
LD map
We examined the extent of LD between the polymorphisms and constructed an LD map under the Malécot model for multiple markers. From the LDMAP program, the swept radius (a measure of the extent of 'useful' LD) was estimated equal to 205.6 kb, suggesting a rather extensive LD in the region. The error variance, V, was also calculated to investigate the fit of the pairwise LD data to the LD map compared to the kb map (Table 3) . LD analysis in a case-control study on GAP C Scapoli et al
The reduction in the error variance between the LDU map (V LDU ¼ 0.592) and kb map (V kb ¼ 1.853) demonstrates the much improved fit of the LD data to the LDU map over the map in kilobases. The corresponding LD map length of the 2q13-14 region was 2.156 LDUs. Figure 3 shows the physical locations of the SNPs against the LDU location. The map shows a broad region of rather extensive LD between IL-1B À511 and IL-1RN markers with only 0.58 LDUs in 293 kb. The most striking feature is the transition between IL-1B þ 3953 and IL-1B À511 with 1.16 LDUs in only 4.48 kb, suggesting that this region may contain a recombination hot spot. 31 Allelic association Single-marker tests (Table 2 ) suggest an association of the disease with the IL-1B þ 3953 marker (P ¼ 0.039), but with little other evidence emerging from the region. In fact, by fitting the four models described in the 'Statistical methods' section, using the Malécot equation and making the comparisons between models A-B, A-C and A-D as described, we found no further significant evidence for the region (Table 4 ). The residual variance (V*) on fitting the LD map was marginally, but nonsignificantly, reduced compared to the kb map. For the LDU map and model C, the residual variance was 0.517 and the location at 0.42 LDUs is very close to the IL-1B þ 3953 polymorphism. Analysis of pairwise haplotypes similarly showed no significant evidence. The two SNP haplotypes comprising IL-1A þ 4845 and IL-1B þ 3953 showed a P-value of 0.143 for the 2-2 haplotype and the lowest P-value achieved was for the IL-1B þ 3953 and IL-1B À511 haplotype, where the 2-1 haplotype showed P ¼ 0.103.
Discussion
Several studies have shown a role for IL-1 gene cluster polymorphisms in the risk assessment for periodontal diseases. 27, 29, 32, 33 The IL-1 cluster, located on chromosome 2, includes the genes IL-1A, IL-1B and IL-1RN. In the LD analysis in a case-control study on GAP C Scapoli et al present study, we have tested polymorphisms, derived from genes of the IL-1 cluster, for association with GAP through both allelic association and by constructing an LD map of the 2q13-14 disease candidate region.
Genetic characterization of GAP patients may offer some advantages for genetic studies both because it shows fewer problems with diagnosis, variable phenotype and age of onset compared to chronic periodontitis, and because a more clearly defined genetic element has been indicated for this form of periodontitis. 34, 35 Moreover, although AP is comparatively rare in the general population, studies of this disorder may reveal genetic variants which may also influence the onset, severity and progression of adult periodontitis. 36 In contrast to genetic associations in chronic periodontitis, several reports on AP indicate that the composite IL-1 genotype is not associated with this form of periodontal disease. 37, 38 Furthermore, there is evidence that allele 1 (rather than allele 2) of the IL-1B þ 3954 SNP is the allele associated with risk of aggressive periodontitis. 37, 39 A further study on this pathology was attempted in a wholly African American population, but allele 1 of the IL-1B þ 3954 was too common in this population to be useful. 40 In a Japanese population, no association between disease and IL-1B þ 3954 , IL-1B À511 or IL-1A þ 4853 SNPs was found, although there was a significant association of AP with IL-1RN intron 2 VNTR genotype. 41 As concerns the role of IL-1RN polymorphism, a study on the UK population failed to find a relationship between AP and IL-1RN intron 2 VNTR genotype. 39 From this study, a weak suggestion of an association of GAP with the IL-1B þ 3953 polymorphism (P ¼ 0.039) emerges. Further, but nonsignificant, support for this result comes from both the model fitting, which gives the LDU location at the peak of this marker, and from the haplotype evidence, which determines the IL-1B þ 3953 -IL-1B À511 haplotype as having the lowest P-value in the region (P ¼ 0.103). This result is in agreement with other studies [37] [38] [39] which identified the IL-1B þ 3953 polymorphism as implicated in AP.
The IL-1RN genotype distribution observed was significantly different in GAP and control subjects (P ¼ 0.019) although the allelic distribution was the same in the two groups (Table 2 ). In a recent publication, Tai et al 41 showed that, in a Japanese population, both the frequency of IL-1RN (VNTR) polymorphic alleles was found to be significantly increased in GAP patients (w 2 test, P ¼ 0.007; OR ¼ 3.40) and also the carriage rate of IL-1RN (VNTR) polymorphisms was significantly higher in GAP patients than in healthy controls (w 2 test, P ¼ 0.005; OR ¼ 3.81). Also, Parkhill et al 39 showed that allele 1 of the IL-1B þ 3953 SNP and allele 1 of the IL-1RN (VNTR) in combination were significantly elevated in GAP as compared to controls in a Caucasian sample. In the Parkhill analysis, a negative LD coefficient (D) was found between these alleles in the control group (D ¼ À423.76) and in the patient group (D ¼ À994.3), indicating that, although the genes lie on the same chromosome 2, they are not in LD, nor are they retained on the same haplotype. 42 Their interpretation was that these genes could act independently, having a cumulative effect on susceptibility to GAP.
Developments in genomics are providing fundamental structural information about the human genome and genomic variation. For example, genotyping studies within individual loci have revealed that haplotypes within particular genetic regions contain 'informative SNPs' and 'redundant SNPs'. The determination of 'haplotype tag SNPs' (htSNPs), 43 generating haplotypes containing only informative SNPs, might be able to reduce the genotyping effort required and to aid investigations of the role of polymorphism and LD across wide regions of the genome.
The LD across the IL-1 cluster is described as 'moderate', and a correlation between physical distance and the degree of LD in the region has been described. 42, 44 Our preliminary results represent a new approach for the study of LD of the 2q14 band, and the LD patterns observed in other studies are easier to understand given the LDU map we have constructed. We are aware that the LD map here presented is based on a few polymorphisms; however, we are reassured on the reliability of our results because Figure 3 shows a pattern closely similar to an independent LDU map of this region constructed from data used in a study of asthma 45 based on 93 SNPs (one SNP every 5.3 kb) covering a region spanning 490.25 kb. Both LDU maps identify the transition between IL-1B þ 3953 and IL-1B À511 with, in the present data set, a variation of 1.16 LDUs in only 4.48 kb. In the Gohlke et al 45 data, a rapid increase in LDUs in the region carrying the IL-1RN gene and the TIC polymorphism was also observed, suggesting that both these regions may contain a recombination hot spot 31 that could be responsible for the independent behaviour of the IL-1B þ 3953 and IL-1RN polymorphisms observed by Parkhill et al.
It has been repeatedly shown that smoking has a negative effect on the course of destructive (ie chronic and aggressive) periodontal disease. In particular, smoking may affect the disease prevalence as well as the severity of the destructive lesions. Therefore, due to the uneven distribution of smokers in our case and control populations, it may be reasonably assumed that part of the difference in the clinical condition between GAP patients and periodontally healthy controls might be attributed to the detrimental impact of smoking on periodontal tissues. It should also be considered that a gene-environmental interaction between smoking and the IL-1 genetic polymorphism has been recently reported: PAG-positive smokers had an enhanced smoking-associated periodontitis risk as compared to their IL-1 genotype-negative counterparts. 46 However, in GAP, Hodge et al 38 failed to detect an association with IL-1 genotypes and smoking status which, when included in the analysis as a covariate, did not influence the results.
Further studies are, therefore, needed to determine whether and to what extent differences in IL-1 genotype polymorphism may affect the onset and severity of the periodontal lesions in GAP patients with different smoking exposure.
We are aware that a second limitation of the present analysis is represented by the limited size of case sample. From a general point of view, the weaknesses of casecontrol studies are well documented: sample selection and study design are two of the most critical elements, but a relatively small sample size is also one of the major reasons for the lack of reproducibility of case-control association studies. 47 The sample size determines the strength of the genetic association that can be confidently detected. Current evidence from complex diseases (with large heritable components) indicates that the predicted odds ratios for many genes may be 1.5 or less 47 and, to identify such associations, as a general rule at least 100 cases and controls should be genetically characterized.
However, in the present study, we have focussed our effort principally on the study of a homogeneous population from both ethnic and clinical points of view. This approach, given the small extent of the Ferrara region, reduces the possibilities for establishing large sample sizes, but the homogeneous population has fewer problems with population stratification. We also note that the case group is of the same magnitude as some other published studies on different ethnic groups. 38, [40] [41] In conclusion, the presence of recombination hot spots between the IL-1B þ 3953 and IL-1B À511 polymorphisms and around the IL-1RN (VNTR) marker suggests that dense SNP typing within these regions will be required to fully determine an extended informative haplotype structure and its possible associations with disease. Greater precision and perhaps significance might be achieved by typing more SNPs in the immediate IL-1B þ 3953 region and, of course, through meta-analysis of other data sets with larger-scale well-controlled designs.
Methods

Statistical methods
Allelic association. It is believed that the complete human sequence contains up to 15 million diallelic polymorphisms in nonrepetitive sequences of coding regions, including introns and promoters. 48 Most SNPs must be quasi-neutral, but a proportion of them contribute to disease susceptibility and resistance. With the present methods, only a fraction of these will be tested even in candidate regions, and so it is unlikely that a causal polymorphism will be included in a random set of associated SNPs. Here, we apply a regression-based method using SNPs genotyped in a sample-based case-control study design where haplotypes cannot be determined, the disease gene frequency (Q) cannot be estimated and thus the (r) metric for association between the disease phenotype and markers cannot be computed.
In the case-control approach, the data comprise genotype counts in the two sets of subjects for a series of SNPs in a candidate region (Table 5a ) and, under Hardy-Weinberg, these genotype distributions can be reduced to a 2 Â 2 table of allele counts (Table 5b ) that give a w 1 2 as:
As the sample is enriched for cases, Collins and Morton 15 developed an enrichment factor (o) which corrects the associated marker allele frequency among controls, to reconstruct the random sample for alleles (Table 5c ). This factor corresponds to the ratio of the number of cases to controls divided by the ratio of the frequency of affection for the trait in the population (z) to the frequencies of normal phenotype: o ¼ n 1 (1Àz)/n 0 z. We can apply the enrichment factor to obtain the regression parameter (b), as:
The Malécot equation 15 : r ¼ (1ÀL)Me (Àed) þ L describes the relationship between association (r) and physical (or genetic) distances. We adapt this equation to predict regression, b, between a SNP marker and disease in terms of four parameters:
where S is a SNP location, Ŝ is the estimated location of a causal SNP, D is 1 if S4(Ŝ ) and À1 otherwise. e is the exponential decline of association with distance (reflecting recombination and time). The asymptote L is an error term, representing the probability of spurious association through population stratification, and is predictable from the sample (Lp) 51 or may be estimated (L). Finally, M represents the intercept and is assumed to be one if the associated haplotype is monophyletic and less than 1 otherwise. The regression coefficient b has affection (0, 1) as the independent variable. The model uses composite likelihood (À2lnL) and the residual variance on fitting the model is 
LD analysis in a case-control study on GAP C Scapoli et al association in the region, without attributing it to a location or subregion. Model C assumes Lp but estimates M and S, which is the location of the peak for association with disease. The most complex alternative hypothesis (model D) estimates L, M and S. We consider three tests based on the difference in À2lnL, namely A-B, A-C and A-D, with each difference divided by the residual variance for the more complex hypothesis. These tests have 1, 2 and 3 degrees of freedom, respectively.
LD map. Maniatis et al
13 extended the Malécot model to construct a LD map, expressed in LD units ( ¼ LDU), discriminating regions of conserved LD and having additive distances and locations monotonic with physical (kb) and genetic (cM) maps. The algorithm, implemented in the LDMAP program (http://cedar.genetics. soton.ac.uk/pub/PROGRAMS/LDMAP), uses the component (ed) of the Malécot equation, as a natural measure of LD. In fact, assuming that recombination (y) dominates systematic pressures, then ed ¼ yt and since (ed) is not biased in favour of the linkage map and is much more accurately known than (yt), it is a more useful metric for LD. The LD map in LDU is constructed such that one LDU is equal to one 'swept radius', that is the distance at which disequilibrium falls to e À1 E0.37 of its initial value. 51 The swept radius is therefore a measure of the extent of 'useful' LD.
We constructed an LD map of the candidate region 2q13-14 and the LDU map provides locations for multilocus model fitting to examine associations with disease phenotype. In fitting the four models, the e parameter is fixed at 1 for the LDU map and at 0.0042, the Malécot estimate, for the kb map following Maniatis et al. We also examined two-SNP haplotypes for association with disease by scoring individuals for the two haplotypes they possess (from the set 1-1, 1-2, 2-1, 2-2), such that each individual had a score that summed to 2. For doubly heterozygous individuals, we scored in probability from the allele frequencies predicted by the method of Hill. 52 The relationship between haplotype scores (X) and affection status (Y) was established by regression in SAS for all adjacent pairs of SNPs.
Study population A total of 40 GAP patients (13 males and 27 females; mean age: 34.374.55 years) and 96 periodontally healthy control subjects were recruited for the present study. All subjects were chosen among current and permanent residents of Ferrara area.
Systemically healthy GAP patients were selected for study among those undergoing periodontal supportive therapy at the Research Center for the Study of Periodontal Diseases, University of Ferrara. The clinical diagnosis at the time of the initial visit was based on a recent classification. 53 The periodontally healthy control subjects were selected if they showed no interproximal attachment loss greater than 2 mm at any of the fully erupted teeth. Controls were matched by age and sex with GAP patients.
In all, 35% of the GAP patients were smokers at the time of initial examination, while all the subjects from the control groups were nonsmokers. For the 14 GAP smoker patients, smoking exposure (expressed as packs of cigarettes smoked per day Â the number of years smoked) was 8.26 (range 0.4-21.3).
All GAP patients and controls were Caucasian Italian, and none of them had a history of diabetes mellitus or current manifestation of systemic diseases, which correlates with destructive periodontal disease. The study design was approved by the local ethical committee and was found to conform to the requirements of the 'Declaration of Helsinki' as adopted by the 18th World Medical Assembly in 1964 and subsequently revised (http://www.wma.net/e/policy/b3.htm). Written informed consent was provided by all participants in line with the Helsinki Declaration before inclusion in the study.
Analysis of genetic polymorphisms
Peripheral (20 ml) blood was taken from each subject, collected into EDTA and then stored at À201C until analysis. Genomic DNA was extracted by the salting out method 54 : DNA was aliquoted in distilled water and the stocks were stored at 41C. DNA integrity was also tested, by running genomic DNA through 0.8% agarose gel, and visualized with ethidium bromide.
We tested the following variants by using primer concentrations, optimized thermocycling conditions and gel compositions as already published in the cited literature: IL-1A homolog (TIC) gene. This region of 273 bp of length was amplified by conventional PCR.
The PCR products for both variants were analysed using the SSCP technique. 59, 60 In all, 2 ml of each amplicon was mixed with 8 ml of a denaturing solution (23.75 ml. of 99% formamide, 1.25 ml of 1% xylene cyanol solution and 10 mg of bromophenol blue) heated for 10 min at 951C, chilled on ice at once, then 6 ml was loaded into the preformed wells of a nondenaturing polyacrylamide precast gel (Amersham Pharmacia Biotech, Cologno Monzese, Italy). After electrophoresis, the gel was stained with the silver nitrate method. 61 For a more accurate identification of the two alleles at these polymorphisms, we purified 2-3 ml of some PCR products with Exonuclease I and Alcaline Phosphatase USB (Amersham Pharmacia Biotech, Cologno Monzese, Italy) enzymes; then they were sent for sequencing with a DNA Analyzer (ABI PRISM 3700 Applied Biosystems, Monza, Italy). For all markers, primers were from MWG Biotech (Firenze, Italy) and the thermocycler used was a GeneAmp PCR System 9700 (Perkin-Elmer, Monza, Italy).
